Sponsor Check › Issuer
Corporation · organized in DELAWARE · formed Over five years ago · NASHVILLE, TN · SEC CIK 1883666
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Oct 21, 2026 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. State securities regulator actions: not yet searched. · Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
Coming soon.
What will be compared: what the sponsor says publicly (website, marketing materials, claimed profile) against what public records show — SEC Form D filings, Form ADV adviser registration, and state business records. Every comparison is reviewed by a person before it is published.
No comparisons published yet.
Sources to be compared: sponsor public claims · SEC Form D · SEC Form ADV (IAPD) · state business records · As of Oct 23, 2026, 9:14 PM ET.
0 of 5 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons.
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Sep 17, 2021 D File 021-413745 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Mar 24, 2022 D File 021-438697 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Feb 9, 2023 D/A File 021-449091 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Nov 13, 2025 D/A File 021-505310 | $0 | $0 | $0 | None listed |
| EDGAR ↗ | Oct 21, 2026 D File 021-602035 | $0 | $0 | $0 | None listed |
As reported by the issuer on Form D (Items 12–15), latest filing per offering. "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates.
Each filing as reported by the issuer. Open a row for the full plain-English detail.
| Filing | Form D filed Oct 21, 2026 SEC file no. 021-602035 · accession 0001883666-26-000001 |
|---|---|
| Raise progress | $320,000 sold of $1,000,000 offered (32%) · $680,000 remaining |
| Filing timing | Date of first sale: Oct 5, 2026 · Form D filed: Oct 21, 2026 (16 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 19 days (0.1 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 2 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $1 |
| Securities offered | Equity |
| Industry / issuer size | Manufacturing · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers, CEO (Oct 21, 2026) |
| Market context | Minimum investment: $1. Typical range for similar offerings: $10,000–$60,000. Offering size: $1,000,000. Typical range: $1,000,000–$7,247,539. Investors: 2. Typical range: 2–13. "Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index |
| Filing | Form D/A (amendment) filed Nov 13, 2025 · amends 0001883666-25-000003 ↗ SEC file no. 021-505310 · accession 0001883666-25-000004 |
|---|---|
| Raise progress | $1,045,000 sold of $2,000,000 offered (52%) · $955,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Nov 13, 2025 (652 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Nov 13, 2025. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 10 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Nov 13, 2025) |
| Changes vs prior filing | total sold: $995,000 → $1,045,000 Compared with the D/A filed Sep 24, 2025 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 10. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Sep 24, 2025 · amends 0001883666-25-000002 ↗ SEC file no. 021-505310 · accession 0001883666-25-000003 |
|---|---|
| Raise progress | $995,000 sold of $2,000,000 offered (50%) · $1,005,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Sep 24, 2025 (602 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Sep 24, 2025. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 10 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Sep 24, 2025) |
| Changes vs prior filing | total sold: $820,000 → $995,000 investors: 8 → 10 Compared with the D/A filed Jul 21, 2025 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 10. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Jul 21, 2025 · amends 0001883666-24-000006 ↗ SEC file no. 021-505310 · accession 0001883666-25-000002 |
|---|---|
| Raise progress | $820,000 sold of $2,000,000 offered (41%) · $1,180,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Jul 21, 2025 (537 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Jul 21, 2025. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 8 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Jul 21, 2025) |
| Changes vs prior filing | total sold: $605,000 → $820,000 investors: 7 → 8 Compared with the D/A filed Oct 11, 2024 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 8. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Oct 11, 2024 · amends 0001883666-24-000004 ↗ SEC file no. 021-505310 · accession 0001883666-24-000006 |
|---|---|
| Raise progress | $605,000 sold of $2,000,000 offered (30%) · $1,395,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Oct 11, 2024 (254 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 7 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Oct 11, 2024) |
| Changes vs prior filing | total sold: $585,000 → $605,000 investors: 6 → 7 Compared with the D/A filed Jun 20, 2024 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 7. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Jun 20, 2024 · amends 0001883666-24-000003 ↗ SEC file no. 021-505310 · accession 0001883666-24-000004 |
|---|---|
| Raise progress | $585,000 sold of $2,000,000 offered (29%) · $1,415,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Jun 20, 2024 (141 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 6 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Jun 20, 2024) |
| Changes vs prior filing | total sold: $560,000 → $585,000 investors: 5 → 6 Compared with the D/A filed Jun 6, 2024 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 6. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Jun 6, 2024 · amends 0001883666-24-000002 ↗ SEC file no. 021-505310 · accession 0001883666-24-000003 |
|---|---|
| Raise progress | $560,000 sold of $2,000,000 offered (28%) · $1,440,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Jun 6, 2024 (127 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 5 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Jun 6, 2024) |
| Changes vs prior filing | total sold: $410,000 → $560,000 Compared with the D/A filed Mar 8, 2024 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 5. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Mar 8, 2024 · amends 0001883666-24-000001 ↗ SEC file no. 021-505310 · accession 0001883666-24-000002 |
|---|---|
| Raise progress | $410,000 sold of $2,000,000 offered (21%) · $1,590,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Mar 8, 2024 (37 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 5 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Mar 8, 2024) |
| Changes vs prior filing | total sold: $400,000 → $410,000 investors: 4 → 5 Compared with the D filed Feb 14, 2024 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 5. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Feb 14, 2024 SEC file no. 021-505310 · accession 0001883666-24-000001 |
|---|---|
| Raise progress | $400,000 sold of $2,000,000 offered (20%) · $1,600,000 remaining |
| Filing timing | Date of first sale: Jan 31, 2024 · Form D filed: Feb 14, 2024 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 997 days (2.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 4 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Feb 14, 2024) |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,000,000. Typical range: $829,831–$9,999,998. Investors: 4. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Feb 9, 2023 · amends 0001883666-22-000007 ↗ SEC file no. 021-449091 · accession 0001883666-23-000001 |
|---|---|
| Raise progress | $550,000 sold of $1,300,000 offered (42%) · $750,000 remaining |
| Filing timing | Date of first sale: May 31, 2022 · Form D filed: Feb 9, 2023 (254 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,607 days (4.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 9 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Feb 9, 2023) |
| Changes vs prior filing | total sold: $475,000 → $550,000 investors: 8 → 9 Compared with the D/A filed Dec 27, 2022 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $1,300,000. Typical range: $829,831–$9,999,998. Investors: 9. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Dec 27, 2022 · amends 0001883666-22-000006 ↗ SEC file no. 021-449091 · accession 0001883666-22-000007 |
|---|---|
| Raise progress | $475,000 sold of $1,300,000 offered (37%) · $825,000 remaining |
| Filing timing | Date of first sale: May 31, 2022 · Form D filed: Dec 27, 2022 (210 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,607 days (4.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 8 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Dec 27, 2022) |
| Changes vs prior filing | total sold: $425,000 → $475,000 Compared with the D/A filed Nov 18, 2022 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $1,300,000. Typical range: $829,831–$9,999,998. Investors: 8. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Nov 18, 2022 · amends 0001883666-22-000004 ↗ SEC file no. 021-449091 · accession 0001883666-22-000006 |
|---|---|
| Raise progress | $425,000 sold of $1,300,000 offered (33%) · $875,000 remaining |
| Filing timing | Date of first sale: May 31, 2022 · Form D filed: Nov 18, 2022 (171 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,607 days (4.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 8 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Nov 18, 2022) |
| Changes vs prior filing | total sold: $325,000 → $425,000 investors: 6 → 8 Compared with the D/A filed Sep 8, 2022 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0. Typical range for similar offerings: $10,000–$54,310. Offering size: $1,300,000. Typical range: $829,831–$9,999,998. Investors: 8. Typical range: 2–15. "Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Sep 8, 2022 · amends 0001883666-22-000003 ↗ SEC file no. 021-449091 · accession 0001883666-22-000004 |
|---|---|
| Raise progress | $325,000 sold of $1,300,000 offered (25%) · $975,000 remaining |
| Filing timing | Date of first sale: May 31, 2022 · Form D filed: Sep 8, 2022 (100 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,607 days (4.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 6 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Sep 8, 2022) |
| Changes vs prior filing | total sold: $300,000 → $325,000 investors: 5 → 6 Compared with the D/A filed Jul 18, 2022 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D/A (amendment) filed Jul 18, 2022 · amends 0001883666-22-000002 ↗ SEC file no. 021-449091 · accession 0001883666-22-000003 |
|---|---|
| Raise progress | $300,000 sold of $1,300,000 offered (23%) · $1,000,000 remaining |
| Filing timing | Date of first sale: May 31, 2022 · Form D filed: Jul 18, 2022 (48 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,607 days (4.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 5 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Jul 18, 2022) |
| Changes vs prior filing | total sold: $150,000 → $300,000 investors: 2 → 5 Compared with the D filed Jun 14, 2022 (EDGAR ↗). Amendment history as filed; no conclusion is drawn. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Jun 14, 2022 SEC file no. 021-449091 · accession 0001883666-22-000002 |
|---|---|
| Raise progress | $150,000 sold of $1,300,000 offered (12%) · $1,150,000 remaining |
| Filing timing | Date of first sale: May 31, 2022 · Form D filed: Jun 14, 2022 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,607 days (4.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 2 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Jun 14, 2022) |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Mar 24, 2022 SEC file no. 021-438697 · accession 0001883666-22-000001 |
|---|---|
| Raise progress | $25,000 sold of $25,000 offered (100%) · $0 remaining |
| Filing timing | Date of first sale: Mar 10, 2022 · Form D filed: Mar 24, 2022 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,689 days (4.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jared Meyers by James B. Young attorney-in-fact, Chief Executive Officer (Mar 24, 2022) |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
| Filing | Form D filed Sep 17, 2021 SEC file no. 021-413745 · accession 0001883666-21-000001 |
|---|---|
| Raise progress | $0 sold of $75,000 offered (0%) · $75,000 remaining |
| Filing timing | Date of first sale: Yet to occur · Form D filed: Sep 17, 2021 Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 2 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 |
| Securities offered | Option, warrant or other right to acquire |
| Industry / issuer size | Other Health Care · revenue range: Decline to Disclose |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Victoria Young, Attorney (Sep 17, 2021) |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set |
All Form D filings for this CIK on SEC EDGAR ↗. History: 1 new offering in the last 12 months · most recent filing Oct 21, 2026 · industry as reported over time: Other Health Care → Manufacturing.
| Name | Relationship | Address state | On filings | Also listed on |
|---|---|---|---|---|
| Jared Meyers | Executive Officer, Director | TN | Sep 17, 2021 → Oct 21, 2026 | — |
| STEPHEN KALINSKY | Director | TN | Feb 14, 2024 → Oct 21, 2026 | — |
| JARED MEYERS | Executive Officer, Director | TN | Feb 14, 2024 → Nov 13, 2025 | — |
| Stephen Kalinsky | Executive Officer, Director | TN | Mar 24, 2022 → Feb 9, 2023 | — |
| Stephen Kalinksky | Executive Officer | NY | Sep 17, 2021 | — |
Executive officers, directors and promoters as self-reported by the issuer. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
No other issuers list the same related persons.
Shared address: this business address appears on no other issuer's filings in our index.
Not yet searched. Sources to be searched: SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet collected. We store official links only (company website, verified via a profile claim) and the earliest archived date of the website; never personal or family accounts.
Export this report as PDF (all source links + data timestamp; members)
No corrections have been requested for this page.
The complete public-record profile for Augment Health, Inc., plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.